Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

F8 IL10

Next Previous
X
Search
Drug Profile

F8 IL10

Alternative Names: Dekavil; F8-IL10; PF 06687234

Latest Information Update: 05 Nov 2023

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Philogen
  • Developer Pfizer; Philogen
  • Class Anti-inflammatories; Antirheumatics; Cytokines; Monoclonal antibodies; Recombinant fusion proteins
  • Mechanism of Action Interleukin 10 replacements
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Phase II Inflammation; Rheumatoid arthritis
  • Discontinued Ulcerative colitis

Most Recent Events

  • 08 Jun 2023 Philogen terminates a phase II trial in Rheumatoid arthritis (Combination therapy) in Italy, Germany, Switzerland (SC), due to the approvals of new agents for the same indication have significantly slowed down the recruitment in this trial making the prosecution of the present investigation extremely difficult (NCT02270632)
  • 18 Nov 2022 Philogen plans a phase I trial for Rheumatoid arthritis (In adults, In the elderly) in March 2023 (intra-articular)(NCT05622175)
  • 24 Dec 2021 Phase-II clinical trials in Inflammation in Italy (IV) (Philogen pipeline, December 2021)

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top